NCT05475613 2024-11-29
Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
Clinical Trials
7 trialsNCT05027425 2024-11-22
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Active not recruiting
NCT06236568 2024-02-07
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
Azienda Ospedaliero-Universitaria di Modena
Phase NA Recruiting
NCT04499833 2022-06-06
HepatoPredict
Centro Hospitalar de Lisboa Central
Phase NA Recruiting
NCT04825470 2022-03-11
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
Phase NA Unknown
NCT01387503 2021-10-11
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Completed
NCT02202564 2014-07-29
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
Huazhong University of Science and Technology
Phase 2 Completed